Fairtility just raised $15 million in series A funding to support its transparent AI analysis technology for better in vitro fertilization (IVF) outcomes.

FDA recently published a set of 10 guiding principles to inform the development of Good Machine Learning Practice.

The biomarker suite has the potential to expand the utility of AI to analyze tissues prepared with the most frequently used stain in histology.

Strong procedure volume recovery drove underlying growth, but headwinds cloud Zimmer Biomet's forecast.

This will be the third clinical-stage program in Xbiome’s growing pipeline supported by AI and biotechnology platforms.

In just over five years GripAble has rocketed from being a laboratory design concept to a therapeutic used in hundreds of centers globally.

The company's software platform has not yet received FDA clearance.

C2i Genomics launches minimal residual disease test across Europe after clearing regulatory hurdles in the EU, UK, and Switzerland.

Artificial intelligence is becoming a core component in all aspects of diagnostics, drug discovery, and more, explains Nandha Balasubramaniam, Head of Digitalomics at Oracle Heath, who will be speaking at MD&M West.

FDA’s clearances are for artificial intelligence (AI) algorithms that detect leading indicators of heart disease.